Drug-eluting stents for the treatment of coronary artery disease

  • Technology appraisal guidance
  • TA152
  • Published: 
  • Last updated: 

Archive: Draft scope

To appraise the clinical and cost effectiveness of newer drug eluting coronary artery stents for the prevention of ischaemic heart disease and to provide guidance to the NHS in England and Wales.

Archive: Draft scope Archive: Draft scope
17 January 2005
(29.84 Kb 8 sec)

This page was last updated: 30 March 2010